MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-BR-26-0020499
Fmedex Private Limited
Fmedex Private Limited - pharma in Patna, Bihar, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹81.21 Lakh
▲ 60% YoY
Net loss · FY 2023
₹20.15 Lakh
Net margin -24.8%
EBITDA · FY 2023
-₹18.78 Lakh
EBITDA margin -23.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Fmedex Private Limited
Data last updated:
Fmedex Private Limited is a private limited company based in Patna, Bihar, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24239BR2021PTC052128. Its GSTIN is 10AAECF5741Q1ZH (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Shobha Ojha and Ashirwad.
Its last annual general meeting (AGM) was held on 20 April 2024, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 12 Kidwaipuri New Capital Patna Bihar, Bihar, India – 800001.
As per the financials filed for FY 2023, the company reported a revenue of ₹81.21 Lakh, a growth of 60% compared to the previous year. For the same year it recorded a net loss of ₹20.15 Lakh (net margin -24.8%) and EBITDA of -₹18.78 Lakh (EBITDA margin -23.1%).
Fmedex Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0020499).
Company details
CIN U24239BR2021PTC052128
Registration Number 052128
Incorporation Date 22 May 2021
ROC Patna
Listing Status Unlisted
Company Status Active
Date of Last AGM 20 April 2024
Date of Balance Sheet 31 March 2023
MSME Classification Micro
Udyam Registration UDYAM-BR-26-0020499
Key People
Shobha Ojha Director Ashirwad Director Anurag Director Recognitions & Rankings of Fmedex
Contact details
Fmedex Private Limited's registered office is in Patna, Bihar. Its e-mail address is in the company report.
- Email
- Registered Address12 Kidwaipuri New Capital Patna Bihar, Bihar, India – 800001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Fmedex Private Limited, buy the company report.
Comprehensive company report
Fmedex Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Fmedex is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Fmedex Private Limited, buy the company report.
Financials of Fmedex Private Limited
FY 2023 filings availableFmedex Private Limited reported revenue of ₹81.21 Lakh (up 60% YoY) for FY 2023.
Revenue · FY 2023
₹81.21 Lakh ▲ 60%
Net loss · FY 2023
₹20.15 Lakh margin -24.8%
EBITDA · FY 2023
-₹18.78 Lakh margin -23.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 60%
Revenue rose 60% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹18.78 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹20.15 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -23.1% | |
| Net Profit Margin | -24.8% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Fmedex Private Limited, buy the company report.
Board of directors of Fmedex Private Limited
Fmedex has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shobha Ojha | Director | 22 May 2021 | 5 Years 5 Months | Current |
| Ashirwad | Director | 22 May 2021 | 5 Years 5 Months | Current |
| Anurag | Director | 22 May 2021 | 5 Years 5 Months | Current |
Peer comparison
Fmedex Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Studio Moda Fabrics Private Limited | ₹81.25 Lakh (FY 2025) | -7.0% | Kolkata, West Bengal, India | |||
| Shri Parbhu Engineering Works Private Limited | ₹81.24 Lakh (FY 2019) | 320.0% | Sonipat, Haryana, India | |||
| Sitanjali Lifestyle Private Limited | ₹81.23 Lakh (FY 2025) | 180.0% | Surat, Gujarat, India | |||
| Ovoid Pharmachem Private Limited | ₹81.22 Lakh (FY 2023) | 136.0% | Hyderabad, Telangana, India | |||
| Ajneri Industries Private Limited | ₹81.21 Lakh (FY 2024) | -10.0% | Jhansi, Uttar Pradesh, India | |||
| Fmedex Private Limitedthis company | ₹81.21 Lakh (FY 2023) | -₹20.15 Lakh | -24.8% | 60.0% | Patna, Bihar, India | |
| Aldo Electricals & Services Private Limited | ₹81.21 Lakh (FY 2022) | -36.0% | Bangalore, Karnataka, India | |||
| Rausd Pharma Private Limited | ₹81.2 Lakh (FY 2025) | 9.0% | Darbhanga, Bihar, India | |||
| Shades Performance Products Private Limited | ₹81.18 Lakh (FY 2018) | -84.0% | Anna Nagar Chennai, Tamil Nadu, India | |||
| Coxa Healthcare Private Limited | ₹81.17 Lakh (FY 2018) | New Delhi, Delhi, India | ||||
| U-Know Mart Private Limited | ₹81.16 Lakh (FY 2017) | -3.0% | Thrissur, Kerala, India |
To see the full peer comparison of Fmedex Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Fmedex Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fmedex Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Fmedex Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
Active EPFO establishments
1
GST
Fmedex has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECF5741Q1ZH | Bihar | Active | 02 Jul 2021 |
To see the full GST registrations and return filing status of Fmedex Private Limited, buy the company report.
Recent activity
Fmedex Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Anurag was appointed as Director on 22 May 2021.
AGM
Fmedex Private Limited last Annual general meeting of members was held on 20 Apr 2024 as per latest MCA records.
Filing
Fmedex Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Patna.
Appointed
Anurag was appointed as Director.
Appointed
Ashirwad was appointed as Director.
Appointed
Shobha Ojha was appointed as Director.
Incorporation
22 May 2021
Fmedex Private Limited was registered on 22 May 2021 with Roc Patna & aged 5 years 5 months as per MCA records.
Frequently asked questions
Fmedex is an active private limited company based in Patna, Bihar, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 May 2021 (5+ years old) and is registered under CIN U24239BR2021PTC052128.
Fmedex has 3 current directors:
- Shobha Ojha - Director
- Ashirwad - Director
- Anurag - Director
The latest financial statements of Fmedex on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 20 April 2024. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Fmedex is 10AAECF5741Q1ZH, registered in Bihar.
The CIN (Corporate Identification Number) of Fmedex is U24239BR2021PTC052128. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fmedex was incorporated on 22 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Fmedex by revenue are Studio Moda Fabrics Private Limited, Shri Parbhu Engineering Works Private Limited, Sitanjali Lifestyle Private Limited, Ovoid Pharmachem Private Limited, Ajneri Industries Private Limited and 5 more, all in the same principal business activity (retail trading).
Anurag was appointed as Director on 22 May 2021. Ashirwad was appointed as Director on 22 May 2021. Shobha Ojha was appointed as Director on 22 May 2021.
Yes, Fmedex is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0020499).
The registered office of Fmedex is at 12 Kidwaipuri New Capital Patna Bihar, Bihar, India – 800001.
Fmedex operates in the pharma industry, in the drug formulation and development segment.